Champer J - Search Results

1

Immunotherapy in invasive fungal infection--focus on invasive aspergillosis.

Lehrnbecher T, Kalkum M, Champer J, Tramsen L, Schmidt S, Klingebiel T. Lehrnbecher T, et al. Among authors: champer j. Curr Pharm Des. 2013;19(20):3689-712. doi: 10.2174/1381612811319200010. Curr Pharm Des. 2013. PMID: 23278541 Review.

2

Protein targets for broad-spectrum mycosis vaccines: quantitative proteomic analysis of Aspergillus and Coccidioides and comparisons with other fungal pathogens.

Champer J, Diaz-Arevalo D, Champer M, Hong TB, Wong M, Shannahoff M, Ito JI, Clemons KV, Stevens DA, Kalkum M. Champer J, et al. Among authors: champer m. Ann N Y Acad Sci. 2012 Dec;1273:44-51. doi: 10.1111/j.1749-6632.2012.06761.x. Ann N Y Acad Sci. 2012. PMID: 23230836

3

Proteomic Analysis of Pathogenic Fungi Reveals Highly Expressed Conserved Cell Wall Proteins.

Champer J, Ito JI, Clemons KV, Stevens DA, Kalkum M. Champer J, et al. J Fungi (Basel). 2016 Mar;2(1):6. doi: 10.3390/jof2010006. Epub 2016 Jan 12. J Fungi (Basel). 2016. PMID: 26878023 Free PMC article.

4

The role of the vaginal microbiome in gynaecological cancer.

Champer M, Wong AM, Champer J, Brito IL, Messer PW, Hou JY, Wright JD. Champer M, et al. Among authors: champer j. BJOG. 2018 Feb;125(3):309-315. doi: 10.1111/1471-0528.14631. Epub 2017 Apr 12. BJOG. 2018. PMID: 28278350 Review.

5

Nuclear translocation of type I transforming growth factor β receptor confers a novel function in RNA processing.

Chandra M, Zang S, Li H, Zimmerman LJ, Champer J, Tsuyada A, Chow A, Zhou W, Yu Y, Gao H, Ren X, Lin RJ, Wang SE. Chandra M, et al. Among authors: champer j. Mol Cell Biol. 2012 Jun;32(12):2183-95. doi: 10.1128/MCB.00320-12. Epub 2012 Apr 2. Mol Cell Biol. 2012. PMID: 22473997 Free PMC article.

6

Macrophage immunomodulation by breast cancer-derived exosomes requires Toll-like receptor 2-mediated activation of NF-κB.

Chow A, Zhou W, Liu L, Fong MY, Champer J, Van Haute D, Chin AR, Ren X, Gugiu BG, Meng Z, Huang W, Ngo V, Kortylewski M, Wang SE. Chow A, et al. Among authors: champer j. Sci Rep. 2014 Jul 18;4:5750. doi: 10.1038/srep05750. Sci Rep. 2014. PMID: 25034888 Free PMC article.

7

Novel CRISPR/Cas9 gene drive constructs reveal insights into mechanisms of resistance allele formation and drive efficiency in genetically diverse populations.

Champer J, Reeves R, Oh SY, Liu C, Liu J, Clark AG, Messer PW. Champer J, et al. PLoS Genet. 2017 Jul 20;13(7):e1006796. doi: 10.1371/journal.pgen.1006796. eCollection 2017 Jul. PLoS Genet. 2017. PMID: 28727785 Free PMC article.

8

Molecular safeguarding of CRISPR gene drive experiments.

Champer J, Chung J, Lee YL, Liu C, Yang E, Wen Z, Clark AG, Messer PW. Champer J, et al. Elife. 2019 Jan 22;8:e41439. doi: 10.7554/eLife.41439. Elife. 2019. PMID: 30666960 Free PMC article.

9

A toxin-antidote CRISPR gene drive system for regional population modification.

Champer J, Lee E, Yang E, Liu C, Clark AG, Messer PW. Champer J, et al. Nat Commun. 2020 Feb 27;11(1):1082. doi: 10.1038/s41467-020-14960-3. Nat Commun. 2020. PMID: 32109227 Free PMC article.

10

Performance analysis of novel toxin-antidote CRISPR gene drive systems.

Champer J, Kim IK, Champer SE, Clark AG, Messer PW. Champer J, et al. Among authors: champer se. BMC Biol. 2020 Mar 12;18(1):27. doi: 10.1186/s12915-020-0761-2. BMC Biol. 2020. PMID: 32164660 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

49 results

Search Page